Document Detail


Retinoic acid can block differentiation of the myocardium after heart specification.
MedLine Citation:
PMID:  9268569     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
While a number of transcription factors that are likely to play a role in cardiac differentiation have recently been described, the signals that lead to the expression of these factors remains poorly understood. Here we report that exposure of Xenopus embryos to continuous low levels of all-trans retinoic acid (RA), starting at the time of neural fold closure, blocks expression of myocardial differentiation markers. The development of the remainder of the embryo is relatively normal, suggesting that retinoic acid can act rather specifically on myocardial precursors. Indeed, the pattern of endocardial gene expression appears to remain unaffected by RA treatment. Although RA blocks myocardial gene expression, a superficially normal heart tube forms. The heart tube, however, fails to loop during subsequent development and never forms beating tissue. The effect of RA treatment on expression of myocardial genes is developmental stage dependent, since no influence is observed after myocardial differentiation has commenced. These data indicate that a vital component of the myocardial determination pathway is sensitive to retinoid signaling.
Authors:
T A Drysdale; K D Patterson; M Saha; P A Krieg
Related Documents :
2360499 - Cardiac abnormalities demonstrated postmortem in four cases of accidental electrocution...
970329 - Noninvasive myocardial imaging with potassium-43 and rubidium-81 in patients with left ...
18639779 - Disopyramide for transient high-degree atrioventricular block in a young patient with a...
6526209 - Severe electrocardiographic abnormalities during arfonad administration.
20392939 - Kv1.1 potassium channel deficiency reveals brain-driven cardiac dysfunction as a candid...
10556749 - Comparative study of different syringes in positive aspiration during inferior alveolar...
17196849 - Myocardial damage in high-risk patients undergoing elective endovascular or open infrar...
2018239 - Epa in the prevention of restenosis post ptca.
6371099 - Intravenous digital subtraction angiography in the assessment of patients with left to ...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Developmental biology     Volume:  188     ISSN:  0012-1606     ISO Abbreviation:  Dev. Biol.     Publication Date:  1997 Aug 
Date Detail:
Created Date:  1997-10-01     Completed Date:  1997-10-01     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  0372762     Medline TA:  Dev Biol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  205-15     Citation Subset:  IM    
Affiliation:
Institute for Cellular and Molecular Biology and Department of Zoology, University of Texas at Austin, Austin, Texas, 78712, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Cell Differentiation / drug effects*
Embryo, Nonmammalian / cytology,  physiology*
Gene Expression Regulation, Developmental / drug effects
Heart / drug effects,  embryology*
Morphogenesis
Organ Culture Techniques
Stem Cells / cytology,  drug effects,  physiology
Tretinoin / pharmacology*
Xenopus laevis / embryology
Grant Support
ID/Acronym/Agency:
HL52746/HL/NHLBI NIH HHS; IBN9553176//PHS HHS; IR15HD32080-01A1/HD/NICHD NIH HHS
Chemical
Reg. No./Substance:
302-79-4/Tretinoin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Model systems for the study of kidney development: use of the pronephros in the analysis of organ in...
Next Document:  Hensen's node provides an endogenous limb-forming signal.